Roivant Sciences ROIV
NASDAQ ROIV
$34.92 +0.22 (+0.63%)
At close: Oct 20, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Current Debt (2021 - 2022)

Updated

Roivant Sciences (ROIV) posted Current Debt of $159.9 million for FY2023 (year ended Mar 31, 2023), up 339.3% from $36.4 million in FY2022.

Analysis

Roivant Sciences (ROIV) Current Debt (2021 - 2022) Analysis & Trends

  • Business Quant data shows ROIV's Current Debt at $36.4 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -5.75 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 64.00 Mn
10 Roivant Sciences 25.19 Bn 8.14 Bn 1.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 159.90 Mn
Jun 30, 2021 36.40 Mn
API Access

Roivant Sciences Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ROIV&period=max&api_key=YOUR_API_KEY